Bio-MM
Description:
Bio-MM Microsphere Extended-Release "Depot" Injectable DDS Technology
For an extended 1-week, 1-month or 3-month treatment of cancers, the Bio-MM DDS is applied to incorporate the drug into microsphere delivery systems via intra-muscular or subcutaneous depot delivery over a period of prolonged delivery time.
Extended-Release Microsphere Injection
- Prolonged Action for 1 week, 1 month, 2 months or 3 months
- Precision and Much Narrower Particle Size Distribution
- Significantly Reduced Initial Drug Release Surge
- Significantly Shortened Onset Time
- Improved In-vivo Stability
- Reduced Toxicity
Bio-MM Microsphere Injection
- Prolonged Circulating Half-life
- Improved Solubility
- Reduced Proteolytic Degradation
- Improved In-vivo Stability
- Less Frequent Administration: Improved Patient Compliance
